References
- O’Brien RJ, Nunn PP. The need for new drugs against tuberculosis. Obstacles, opportunities, and next steps. Am J Respir Crit Care Med 2001;163:1055–1058.
- Brennan PJ, Nikaido H. The envelope of mycobacteria. Ann Rev Biochem 1995;64:29–63.
- Trias J, Jarler V, Benz R. Porins in the cell wall of mycobacteria. Science 1992;258:1479–1481.
- Sensi P, Grassi GG. Antimycobacterial agents. In: Wolff ME, editor. Burger’s Medicinal Chemistry and Drug Discovery. Vol. 2: Therapeutic Agents. 5th ed. New York: John Wiley and Sons; 1996. p 575–635.
- Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C. The growing burden of tuberculosis— global trends and interactions with the HIV epidemic. Arch Int Med 2003;163:1009–1021.
- Rattan A, Kalia A, Ahmed N. Multidrug-resistant mycobacter- ium tuberculosis: Molecular perspectives. Emerg Infect Dis 1998;4:196–209.
- Collins L, Franzblau SG. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacter- ium avium. Antimicrob Agents Chemother 1997; 41:1004–1009.
- Ghose AK, Crippen GM. Atomic physicochemical parameters for three-dimensional-structure-directed quantitative struc- ture-activity relationships. 2. Modeling perspectives and hydrophobic interactions. J Chem Inf Comput Sci 1987;27:21–35.